Turkish Journal of Medical Sciences
Volume 39

Number 6

Article 14

1-1-2009

Imaging liver transplantation candidates using gadolinium
enhanced MDCT angiography
ABDUL MECİT KANTARCI
IRMAK DURUR SUBAŞI
BÜLENT AYDINLI
CİHAN DURAN
SELİM DOĞANAY

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
KANTARCI, ABDUL MECİT; SUBAŞI, IRMAK DURUR; AYDINLI, BÜLENT; DURAN, CİHAN; DOĞANAY, SELİM;
POLAT, K. YALÇIN; KANTARCI, RAGİBE; OĞUL, HAYRİ; and ATAMANALP, S. SELÇUK (2009) "Imaging liver
transplantation candidates using gadolinium enhanced MDCT angiography," Turkish Journal of Medical
Sciences: Vol. 39: No. 6, Article 14. https://doi.org/10.3906/sag-0902-16
Available at: https://journals.tubitak.gov.tr/medical/vol39/iss6/14

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Imaging liver transplantation candidates using gadolinium enhanced MDCT
angiography
Authors
ABDUL MECİT KANTARCI, IRMAK DURUR SUBAŞI, BÜLENT AYDINLI, CİHAN DURAN, SELİM DOĞANAY, K.
YALÇIN POLAT, RAGİBE KANTARCI, HAYRİ OĞUL, and S. SELÇUK ATAMANALP

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol39/iss6/14

ORIGINAL ARTICLE

Mecit KANTARCI1
Irmak DURUR SUBAŞI1
Bülent AYDINLI2
Cihan DURAN3
Selim DOĞANAY4
K. Yalçın POLAT2
Ragibe KANTARCI5
Hayri OĞUL1
S. Selçuk ATAMANALP2

1

2

3

4

5

Department of Radiology,
Faculty of Medicine,
Atatürk University,
Erzurum - TURKEY
Department of General Surgery,
Faculty of Medicine,
Atatürk University,
Erzurum - TURKEY
Department of Radiology,
Florence Nightingale Hospital,
Bilim University,
İstanbul - TURKEY
Department of Radiology,
Develi Government Hospital,
Kayseri - TURKEY
Department of Internal Medicine,
Faculty of Medicine,
Atatürk University,
Erzurum - TURKEY

Received: February 19, 2009
Accepted: August 03, 2009

Correspondence
Mecit KANTARCI
200 Evler Mah. 14. Sok. No 5
Dadaşkent, Erzurum - TURKEY
akkanrad@hotmail.com

Turk J Med Sci
2009; 39 (6): 909-916
© TÜBİTAK
E-mail: medsci@tubitak.gov.tr
doi:10.3906/sag-0902-16

Imaging liver transplantation candidates using
gadolinium enhanced MDCT angiography
Aim: To report our experience with gadolinium enhanced computed tomography angiography (GdCTA) for end-stage liver disease patients who are candidates for liver transplantation as an alternative
to iodinated contrast enhanced CTA and gadolinium enhanced magnetic resonance (MR)
angiography.
Materials and methods: Seventeen patients with end-stage liver disease were evaluated with GdCTA. The patients were 10 men (58.8%) and 7 women (41.1%) (age range: 37-59 years). Multidetector
CT (MDCT) was performed using 16-detector-row CT scanners. 3D images of the celiac artery,
superior mesenteric artery, portal vein, and inferior vena cava (IVC) were obtained for thorough
assessment using multiple plane reconstruction and maximum-intensity projection. Adequate images
were defined by complete opacification of the celiac, superior mesenteric, hepatic propria, bilateral
hepatic arteries, main portal vein and bilateral intrahepatic portal branches, and IVC.
Results: All 17 Gd-CTAs were rated as diagnostic. Adequate CT arteriography (celiac, common
hepatic, hepatic propia, and bilateral hepatic artery) and portography were obtained in all the patients.
Engorged gastric and coronary varices were detected in 5 patients (29.4%). Severe splenorenal shunt
was found in 2 patients (11.7%). Thrombus of the portal vein was observed in 3 patients (17.6%). The
radiological findings and operational findings were not discordant in any of the operated patients.
Conclusion: The degree of enhancement and image quality achieved using these gadoliniumenhanced MDCT angiographies appear adequate for angiographic evaluation of liver transplantation.
Therefore, the use of 3D Gd-CTA in selected cases and settings can be advantageous in the
pretransplantation evaluation.
Key words: Liver Transplantation, candidates, gadolinium, MDCT angiography

Karaciğer nakil adaylarının gadolinyum destekli çok kesitli
bilgisayarlı tomografi anjiografi ile görüntülenmesi
Amaç: Bu çalışmanın amacı son dönem karaciğer yetmezlikli, karaciğer nakli adaylarının iyotlu
kontrast ajan kullanılan bilgisayarlı tomografik anjiyografi (BTA) ve gadolinyum kullanılan MR
anjiyografiye alternatif olarak gadolinyum kullanılarak yapılan BTA (Gd-BTA) ile ilgili
deneyimlerimizin aktarılmasıdır.
Yöntem ve gereç: On yedi adet son dönem karaciğer yetmezlikli hasta Gd-BTA ile değerlendirildi.
Hastaların 10’u erkek(% 58,8) ve 7’si kadındı (% 41,1) (yaş aralığı; 37-59). Çok kesitli BT olarak 16
dedektör sıralı tarayıcı kullanıldı. Çöliak arter, superior mezenterik arter, portal ven ve inferior vena
kava (IVC) ’nın 3 boyutlu ve çok düzlemli rekonstrüksiyon görüntüleri elde edildi. Görüntülerin
yeterliliği çöliak arter, superior mezenterik arter, arteria hepatic propiria, her iki hepatic arter, ana
portal ven, her iki taraf portal dallar ve İVC nın tam opakifikasyonu elde edilerek tanımlandı.
Bulgular: Gd-BTA ile yapılan 17 çekimin tümü tanısal olarak değerlendirildi. Çöliak, ana hepatik,
hepatika propiria ve her iki taraf hepatik arterlerin BT arteriyografileri ve portografiler tüm hastalarda
elde edildi. Genişlemiş gastrik ve coroner varisler 5 hastada (% 29,4) belirlendi. Ciddi splenorenal şant
ise 2 hastada belirlendi. Üç hastada portal vende thrombüs gözlendi (% 17,6). Ameliyat edilen
hastaların hiçbirinde radyolojik ve ameliyat esnasında elde edilen bulgular arasında uyumsuzluk
yoktu.
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Sonuç: Gd-BTA ile son dönem karaciğer nakli bekleyen hastalar için yapılan anjiografik
değerlendirilmede görüntülerin yoğunluğu ve tanısal kaliteleri yeterli düzeyde tespit edildi. Bu
nedenle 3 boyutlu Gd-BTA nın seçilmiş hastalarda kullanımı, nakil öncesi vasküler yapıların tanısal
değerlendirmesinde başarılı bir görüntüleme yöntemi olarak göz önünde bulundurulabilir.
Anahtar sözcükler: Karaciğer nakli, alıcı adayları, gadolinyum, çok kesitli BT anjiyografi

Introduction
Nowadays, liver transplantation has been used
more commonly for patients with end-stage liver
disease (1,2). In this context, imaging of the liver
transplantation candidates is of great importance
because the findings can influence the surgical
planning and even the operation type. Computed
tomography, magnetic resonance imaging, and
conventional angiography have been widely used for
this purpose. In the cross-sectional imaging of the
liver transplantation candidates, each of these
modalities has some disadvantages. Imaging with
iodinated contrast material may result in irreversible
deterioration of renal function (3). In addition,
magnetic resonance angiography has several
limitations (3-5) and is often insufficient before
surgical treatment (3). For these reasons, gadolinium
enhanced computed tomography angiography (GdCTA) may be a solution in the situations where
iodinated contrast material and magnetic resonance
imaging are not preferred. Considering all of the
above-mentioned
reasons,
successful
and
interpretable Gd-CTA applications in imaging of
vascular structures of various body areas have recently
been available in the literature (6-8). The purpose of
this study is to report our experience with Gd-CTA
for the end stage liver disease patients who are
candidates for liver transplantation as an alternative
to iodinated contrast enhanced CTA and gadolinium
enhanced MR angiography prospectively. To our
knowledge, no data have been reported about the use
of gadolinium-based contrast agents in the CT
angiographic evaluation of hepatic circulation.
Materials and methods
In Atatürk University Hospital and Florence
Nightingale Hospital, 17 patients (10 men) with endstage liver disease who had indications for liver
transplantation were evaluated with Gd-CTA. The
mean age of the patients in this study group was 48
910

years (age range: 37-59 years). The institutional ethics
committee approved the study, and signed informed
consent was obtained from each patient. The
procedures used were in accordance with the
recommendations found in the Helsinki declaration.
Multidetector CT was performed on 2 different
16-detector-row CT scanners (Aquillon; Toshiba
Medical Systems, Tokyo, Japan; and Sensation16;
Siemens Medical Systems, Forchheim, Germany).
With the first scanner, the following parameters were
applied: 16 × 0.5-mm collimation, 1.0-mm slice
thickness, and 1.0-mm reconstruction interval. On
the second scanner, images were obtained with 12 ×
0.75-mm collimation, 1-mm slice thickness, and 0.6mm reconstruction interval.
Each patient received a maximum dose of 0.3
mmol/kg of body weight of 0.5 mmol/mL gadoterate
meglumine (Dotarem; Guerbet, Paris, France). The
corresponding volume of the contrast material was
injected intravenously at 4.5 mL/s. The fixed delay
technique was used for the starting time of scanning.
Twenty-five seconds after the injection of the
contrast medium, arterial phase was taken in one
breath-hold, followed by 1 portal venous phase at 55
s and 1 systemic venous phase at 120 s after the
injection of the medium.
3D images of the celiac artery, superior mesenteric
artery, portal vein, and inferior vena cava (IVC) were
obtained for thorough assessment using multiple
plane reconstruction and maximum-intensity
projection performed by radiologists. The 3D CTA
was interpreted by 2 radiologists (radiologists
experienced 10 (MK) and 5 years (IDS)) at the
workstation (Vitrea 2, VITAL Images, Inc.
Minnetonka, Minnesota, USA) after viewing the raw
data and the reformatted images in projection views
and axial imaging.
Adequate images were defined by complete
opacification of the celiac, superior mesenteric,
hepatic propia, bilateral hepatic arteries, main portal
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vein and bilateral intrahepatic portal branches, and
IVC. The imaging results were compared with the
operative findings for the patients who underwent
surgery.
Results
Seventeen patients with end stage liver disease
were included for pretransplant evaluation. All 17 GdCTAs were rated as diagnostic. No adverse events
occurred after the intravenous injection of
gadolinium. The examination was well-tolerated, and
the patients did not report any discomfort. The serum
creatinine level remained stable on the first day after
the procedure.
All the Gd-CTA images were found as adequate
for illustration of the celiac, common hepatic, hepatic
propia, and bilateral hepatic artery in all 17 patients
(Figure 1a, b). No pathological findings with arterial
system that could hinder liver transplantation were

December 2009

detected. There was only one (5.8%) vasculary
anatomic variant in our patient population: replace
right hepatic artery that originated from the superior
mesenteric artery (Table).
Adequate CT portography was obtained in all the
patients (Figure 2a, b). Splenomegaly was detected in
all the patients. Engorged gastric and coronary varices
(>1 cm) were detected in 5 patients (29.4%). Severe
splenorenal shunt (3 mm) was found in 2 patients
(11.7%), in whom shunt closure during
transplantation was advised. Thrombus of the portal
vein was observed in 3 patients (17.6%). In 2 of these
patients (11.7%) (2 male), thrombectomy was
performed intraoperatively and transplantation was
carried out (Figure 3a, b). In the other patient
(female), thrombus was widespread; thus,
thrombolitic therapy was applied and the operation
was postponed. In the other 14 patients (82.3%), no
findings that could prevent transplantation with
respect to the portal vein were detected. There was a

Figure 1. A 46-year-old man who was a liver transplantation candidate. A, Axial MIP
image and B, 3D Volume-rendered images show all arterial structures (celiac,
common hepatic, hepatic propia, and bilateral hepatic artery) well. Ao: Aorta,
CHA: common hepatic artery, RHA: right hepatic artery, LHA: Left hepatic
artery, CT: Celiac truncus, SA: Splenic artery.

Table. Pathologic findings and anatomic variants depicted by gadolinium-enhanced CTA.

Engorged gastric and coronary varices
Severe splenorenal shunt
Thrombus of portal vein
Hepatic artery anatomic variant
Splenomegaly
Portal trifurcation

Patient (n)

%

5
2
3
1
17
1

29.4
11.7
17.6
5.8
100
5.8
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Figure 2. A 38-year-old woman who was a liver transplantation candidate. A, Axial MIP
image and B, coronal MIP image shows all portal system. Pv: Portal vein.

Figure 3. A 54-year-old man who was a liver transplantation candidate. A, Coronal MIP
image and B, axial MIP images shows thrombus of the portal vein and superior
mesenteric veins. MPV: Main portal vein, SMV: Superior portal vein, SV:
Splenic vein, Black arrows: Thrombus.

patient (5.8%) with portal trifurcation for which 2
separate anastomoses were needed. All CTAs of the
IVC were adequate. No vascular abnormalities were
found. In addition no local parenchymal lesion was
detected. The radiological findings and operational
findings were not discordant in any of the patients
that underwent surgery.
Discussion
Preoperative imaging of both hepatic vessels and
parenchyma in liver transplantation is beneficial to
better surgical planning or even precludes the
necessity for surgery. Computed tomography (CT),
magnetic resonance (MR) imaging, and conventional
angiography have been all useful for this purpose.
Nonetheless, there are some problems with these
techniques: angiography is an invasive procedure
912

using a large amount of iodinated contrast medium,
which may be nephrotoxic and which finally increases
the risks for liver transplantation recipients (9). The
kidney is an important organ often involved in
complications of liver transplantation (10-12). CT also
uses iodinated contrast medium. Among the large
number of patients who cannot receive iodinated IV
contrast because of contraindications including renal
failure or insufficiency as well as a history of a
previous significant contrast reaction, there is a subset
of patients who also cannot undergo MR angiography
because of contraindications including pacemakers,
surgical clips, uncontrollable motion, claustrophobia,
or postoperative change that could affect the MR
signal (7,13). In some of these patients, problems
associated with acidosis such as tachypnea and
inability to hold breath are observed. This is one of
the obstacles to obtaining good images in MR. In 10
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of the patients (58.8%) blood creatinine level was
slightly higher than normal (level range: 2-4 mg/dL).
Also in 7 of the patients (41.1%) blood creatinine level
was higher than normal (level range: 5-8 mg/dL), but
the serum creatinine level remained stable on the first
day after the procedure. Another aspect in our
research is that 11 of the patients (64.7%) had inability
to hold breath, 5 (29.4%) had claustrophobia, and 1
(5.8%) had surgical clips. Therefore, we did not have
sufficient image quality of MR examinations. Gd-CTA
may be appropriate for these patients in need of
noninvasive vascular imaging but who have
contraindications to both iodinated contrast and MR
(13).
Renal dysfunction frequently attends end-stage
liver disease because of the association between
primary organ disease and hemodynamic interactions
(14). In addition, survival postliver transplant
correlates with pretransplant renal function (15).
Gadolinium-based agents, routinely used for MR
imaging, are safe, well-tolerated, and have shown no
nephrotoxicity for doses up to 0.4 mmol/kg of body
weight (3,16,17). In addition, because of its high
atomic number (64 vs. 53 for iodine), X-ray
attenuation can be expected, although the
commercially available gadolinium chelate solutions
are less concentrated (0.5 molar) than iodinated
contrast agents (3).
The pharmacokinetic behavior of intravenously
delivered Gd-DTPA is similar to that of iodinated
contrast agents used in urography and angiography.
Excretion is predominantly through glomerular
filtration, with a plasma half-life of about 90 min (18).
The plasma half-life increases in relation to the degree
of renal insufficiency. Presently, there is no evidence
of instability or dissociation of the gadolinium chelate
during a prolonged period of retention in the body,
which could lead to the release of toxic gadolinium
ions. For doses, 0.5 mmol/kg of body weight, serum
creatinine and serum urea–nitrogen show no
deviations outside the physiologic range of variation
(3).
The first clinical use of gadolinium as a contrast
agent for CT was reported by Bloem and Wondergem
(13,19). In their study, gadolinium was seen in the
bladder. Quinn et al. (20) demonstrated adequate
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enhancement of the circle of Willis in a single
volunteer. Lumboldt et al. (21) achieved sufficient
enhancement for the assessment of thoracic and
abdominal aortic aneurysms and staging of
carcinoma of the thyroid. Additional case reports
followed (19,20,22,23), including successful depiction
of pulmonary embolism (24). Rosioreanu et al.
reported the use of multidetector Gd-CTA to create
3-dimensional images of the neck (13).
Karcaaltincaba and Foley administered a nonionic
preparation of gadolinium, to exclude an aortic
dissection in a patient who had a pacemaker and an
elevated creatinine level (6). Sam et al. studied the
safety of gadolinium contrast angiography in patients
with chronic renal insufficiency and concluded that,
despite reports of negligible nephrotoxicity, rarely
gadolinium based contrast agents can cause acute
renal failure in patients with underlying chronic renal
insufficiency. Patients at high risk should be
identified, and prophylactic measures should be taken
to reduce the risk for nephrotoxicity (25).
The use of newer CT scanners with decreased
acquisition times should lower the mmol/kg used in
each patient to levels of 0.4 to 0.5 mmol/kg or less,
while maintaining very good or excellent
opacification of the central arterial system. With the
use of routine very thin sections, there should
probably be good to excellent opacification of smaller
arterial structures as well although this should be the
subject of formal investigations. Although Gd-CTA
has limitations compared with MRA and CTA with
iodinated contrast, as parenchymal organs are not
optimally evaluated at doses of 0.5 mmol/kg or lower,
it has been a very useful problem-solving technique
in patients who cannot undergo MRA or conventional
CTA in our experience. Despite these concerns, we
think that carefully selected and monitored patients
do benefit from Gd-CTA, particularly if 16- or more
detector CT scanners are used (13,26).
There is controversy about the use of high-dose
gadolinium for conventional angiography and for its
use in conjunction with CTA. In either instance,
gadolinium is being used off-label, and this should
probably be explained to patients while obtaining
informed consent (27). The manufacturer (and FDA
approved) recommended dose for MR is 0.1 mmol/kg
body weight although up to 0.3 mmol/kg is used
routinely for body MR angiographic studies (28).
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Limitations about this study include the high cost
of Gd-DTPA, which is approximately 4.5 to 6.5 times
more than that of an iodinated nonionic contrast
agent, and there is unknown toxicity in humans at
high doses (0.8 mL/kg body weight), especially in
patients with renal failure (3). Selective injections
should therefore be favored, and examinations limited
to patients with azotemia or with a serious
contraindication to iodine (3).
Clinical trials and extensive clinical experience
have proven that gadolinium-based contrast agents
are safe in patients with normal kidney function. As
renal function deteriorates, however, the safety of
these agents diminishes. Nephrogenic systemic
fibrosis (NSF) is associated with gadolinium chelates
and occurs exclusively in patients with decreased
renal function (29). Patients with liver disease and
those who have undergone liver transplantation seem
to be at increased risk of developing NSF (29).
According to Kirchin et al. MR contrast materials at
doses used for MR imaging lack the nephrotoxicity
associated with iodinated ones (30). The differences
in the effects of various gadolinium preparations are
attributable to gadolinium’s capacity to dissociate
from chelates. The longer dissociation constant of
some chelates is probably a function of their cyclic
structure; most other gadolinium chelates have a
linear structure. Release of gadolinium from a cyclic
chelate requires all 4 covalent bonds to be broken
simultaneously. The more flexible structure of linear
chelates, the more readily facilitates gadolinium
release. This fact might account for the higher
incidence of NSF associated with gadodiamide and
gadopentetate dimeglumine. In patients like ours,
even if MR were performed instead of CT, the use of
Gd chelates would be required. The Gd preparation
we used is in cyclic form and, to our knowledge, there
is no NSF case reported to be associated with
gadoterate meglumin. Thus, in our study, this agent
was preferred for use.
Occluded portal vein, the most common
pathologic
entity
that
complicates
liver
transplantation, is manageable with newer surgical
techniques such as direct venous graft, jump graft,
and even hemiportocaval anastomosis (31-34). A
different and more complicated surgical technique
concerning vascular anastomosis is needed
914
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(compared with cadaveric liver transplantation) in the
presence of congenital vascular anomalies (35).
However, these complicated procedures may cause
high morbidity or even require a second
transplantation (36). Portosystemic shunt is a
complicated condition encountered in liver
transplantation. Decreased portal inflow to the graft
during the operation would result in graft failure (37).
Demonstration of the size and distribution of the
shunt with adjacent anatomic indications in the
abdominal and retroperitoneal cavity facilitate the
ligation for both superficially and deeply located
shunts (36).
In our experience, all the CT examinations
performed with gadolinium-based contrast agents
achieved appropriate vascular enhancement and
allowed radiologists to get accurate diagnostic
information. Based on our results involving 17
patients evaluated with a 16-detector-row CT scanner,
we conclude that Gd-CTA can be considered an
alternative technique for the evaluation of the hepatic
circulation in certain patients with contraindications
to traditional iodinated contrast agents and MR. The
increased speed of data acquisition allows marked
vascular contrast and less motion artifacts. It is
performed in an outpatient setting. Furthermore,
gadolinium-based
contrast
enhanced
CT
examinations are useful for evaluation of hepatic
parenchyma such as vascular structure.
Our preliminary results showed good diagnostic
accuracy of Gd-CTA in comparison with operative
findings. Nevertheless, further research with a larger
sample of patients is needed to validate these
encouraging results.
Conclusion
This clinical experience with gadoliniumenhanced multislice 3D CTA in our institute was
acceptable, definitive, noninvasive, fast, and easy.
Although gadolinium chelates have been reported to
be able to cause NSF, we think that the use of 3D GdCTA with macrocyclic chelates in selected cases and
settings for evaluation of parenchyma and vascular
structure may be an alternative for MRI and iodinated
CT in pretransplantation evaluations.
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